LifeStance director awarded 45,495-share equity grant
LifeStance Health Group, Inc. director Kenneth A. Burdick reported an equity award under which he acquired 45,495 shares of common stock at $0.0000 per share, characterized as a grant or award acquisition.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. director Kenneth A. Burdick reported an equity award under which he acquired 45,495 shares of common stock at $0.0000 per share, characterized as a grant or award acquisition. Following this award, he reports 3,470,810 shares held directly and 46,511 shares held indirectly through Burdick Family LLC. His reported holdings include 45,495 restricted stock units, each representing a contingent right to receive one share of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 45,495 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. Includes 45,495 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
Key Figures
Key Terms
restricted stock units financial
contingent right financial
indirect financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LifeStance Health Group (LFST) director Kenneth Burdick report?
What do the 45,495 restricted stock units (RSUs) in LifeStance (LFST) mean?
Was Kenneth Burdick’s LifeStance (LFST) Form 4 a market purchase or sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.